Long-Term Follow-Up Safety and Preliminary Efficacy Study of Human Central Nervous System Stem Cell (HuCNS-SC Rm) Transplantation in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD) [FOLLOW UP OF 700230643]

Trial Profile

Long-Term Follow-Up Safety and Preliminary Efficacy Study of Human Central Nervous System Stem Cell (HuCNS-SC Rm) Transplantation in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD) [FOLLOW UP OF 700230643]

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2016

At a glance

  • Drugs Adult neural stem cells (Primary)
  • Indications Pelizaeus-Merzbacher disease
  • Focus Adverse reactions
  • Most Recent Events

    • 11 May 2016 Status changed from active, no longer recruiting to completed.
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top